Ophthalmic Pharmaceutical receives DFI investment
A consortium led by SPE Capital, alongside EBRD, Proparco and BIO, closed an equity investment in Orchidia Pharmaceutical Industries in...
A consortium led by SPE Capital, alongside EBRD, Proparco and BIO, closed an equity investment in Orchidia Pharmaceutical Industries in...